chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Information has been received from a health professional referring to a patient of unknown age and gender. Patient's relevant medical history, concurrent conditions and drug reactions/allergies were not reported. On 31-JUL-2015, the patient was vaccinated with second dose of ZOSTAVAX (strength, dose, frequency, lot # unspecified). Concomitant medications were not provided. On 17-JUN-2015, patient received the first dose of ZOSTAVAX. No adverse experience was reported. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site warmth, Oral mucosal blistering, Pain, Pain in extremity, Pyrexia
Clinical narrative: Huge, warm, red, hot welt around injection site. Dr put her on AUGMENTIN.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth, Urticaria
Clinical narrative: Huge, warm, red, hot welt around injection site. Dr put her on AUGMENTIN.
Age: 36.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Erythema, Joint range of motion decreased, Musculoskeletal pain, Neutrophil count increased
Clinical narrative: Severe shoulder pain, low-grade fever, chills, decreased range of motion secondary to pain, edema, erythema, elevated WBC/ANC.
Age: 36.0
Sex: M
Vaccine: PPV
Symptoms: Oedema, Pyrexia, White blood cell count increased
Clinical narrative: Severe shoulder pain, low-grade fever, chills, decreased range of motion secondary to pain, edema, erythema, elevated WBC/ANC.
Age: 72.0
Sex: F
Vaccine: PNC13, VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Patient reported a mild shingles rash on her hand and wrist. No itching or pain was reported.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Expired product administered
Clinical narrative: Injected expired Zostavax vaccine.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: Injected expired Zostavax vaccine.
Age: 64.0
Sex: M
Vaccine: PNC13
Symptoms: Chest discomfort, Dyspnoea, Joint stiffness
Clinical narrative: TIGHTNESS THROUGH SHOULDER AND CHEST CONTINUING FOR ABOUT A WEEK AND A HALF AFTER INJECTION.  ALSO EXPERIENCE SENSATION OF DIFFICULTY BREATHING OVER THE COURSE OF TIME.
Age: 31.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Pain, Paraesthesia
Clinical narrative: Patient had typical local injection site pain for first days. Then several days after she experienced shooting pain from the shoulder down to fingers with tingling in fingers in same arm as injection. She is not sure the symptoms are related, but as a pharmacist and administrator, I did refer her to see her physician since the pain is high level and persisting 12 days after the injection.
Sex: U
Vaccine: HPV9, MNQ, VARCEL, HEP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV9, MNQ, VARCEL, HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: JEV1, YF
Symptoms: Nervousness, Presyncope, Respiratory rate increased, Syncope
Clinical narrative: Pt receiving multiple immunizations, prior to travel. Pt very nervous about needle, and immunizations. Answered all pt questions & explained process. Gave 1st immunization Japanese Encephalitis and pt was fine. Then administered 2nd yellow fever & pt became very nervous & breathing rapidly. Pt then had vasovagal/fainting reaction lasting < 5 min. Pt had water & orange and waited in waiting room for approximately 30 minutes. Felt better when parent picked her up to take home.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema
Clinical narrative: Pt had Dtap in thigh with IPV on side of Right leg. Both areas sl red. Mom applied cool compresses. But redness is getting worse. Anterior sl firm. Light red area about 20 cm. Side thigh with mild redness (streak) about 1cm. Pt was put on AUGMENTIN.
Age: 47.0
Sex: U
Vaccine: HEP
Symptoms: Eye pruritus, Eye swelling
Clinical narrative: Swollen and itching eyes - treated with hydroxyzine and prednisone taper.
Age: 58.0
Sex: M
Vaccine: FLUC3, VARZOS
Symptoms: Erythema, Feeling hot, Inflammation, Pain, Pyrexia
Clinical narrative: Swelling about 4 inches in diameter, redness, soreness, fever.
Age: 58.0
Sex: M
Vaccine: FLUC3, VARZOS
Symptoms: Swelling
Clinical narrative: Swelling about 4 inches in diameter, redness, soreness, fever.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 17-MAR-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 13-FEB-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 09-MAY-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 24-FEB-2015 and 24-APR-2015, the patient was respectively vaccinated with improperly stored GARDASIL (lot #K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 19-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. ON 17-MAR-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Peripheral swelling, Pruritus
Clinical narrative: Information has been received from a patient of unknown age and gender referring to them self. Patient's relevant medical history, concurrent conditions and drug reactions/ allergies were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (strength, dose/frequency, lot # unspecified). No concomitant medications were reported. Patient reported that they had a bad reaction in their arm where they received the shingles shot. Patient stated that their arm swelled and it was all red around the injection area. The patient had a 4-inch long redness by 3-inch wide circle and was placed on antibiotic. They had to get injection to relieve swelling and itching. Outcome of the events were unknown. Patient stated that it was not a good experience. Causality assessment was not provided. Additional information is not expected as the reporter did not wish further contact.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a pharmacist via company representative referring to a patient of unknown demographics. Patient's relevant medical history, concurrent conditions and drug reactions/allergies were not reported. Reporting pharmacist stated that on an unspecified date (reported as a long time ago), the patient received ZOSTAVAX (strength, dose/frequency, lot # unspecified) that may have been improperly stored. Concomitant medications were not reported. No adverse effect was reported. Additional information is not expected as the reporter did not wish further contact.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Fatigue, Headache, Myalgia, Pain
Clinical narrative: Information has been received from a 53 year old female referring to herself. Patient's pertinent medical history and previous drug allergies were unspecified by the reporter. On 06-AUG-2015 the patient was vaccinated with PNEUMOVAX 23, (strength, dose were not reported) intramuscular. No concomitant medications were reported. After receiving vaccine on an unknown date in August 2015 the patient experienced muscle pain, headache, fatigue and soreness. Patient has not communicated with or sought treatment from her provider concerning her adverse events. The outcome of pain, headache, fatigue and myalgia was reported as not recovered. The reporter did not provide the causality between the events and the suspect therapy. There was no product quality complaint. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 24-FEB-2015 and 24-APR-2015, the patient was respectively vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 05-FEB-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 19-JAN-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storaeg). No adverse symptoms were reporetd. This is one of several erports received from the same reporter. Additional information has been rquested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 13-MAR-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 12-JAN-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 05-JAN-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 30-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 23-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 02-FEB-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event, Product quality issue
Clinical narrative: Information has been received from a pharmacist referring to a patient of unknown age and gender. Concurrent condition and medical history were not reported. On 11-AUG-2015 the patient was vaccinated with a dose of expired ZOSTAVAX (dose, lot# and route were unknown, expiration date 20-MAR-2015) (Expired product administered). No concomitant therapy information was provided. Unspecified product quality issue (PQC) was involved. No adverse events were reported. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unkonwn age and gender. Information about medical history and concurrent condition was not reported. On 23-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006262 with expiration date of 17-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 12-JAN-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 17-DEC-2015; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014 the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K006682 with expiration date of 31-DEC-2015; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: DTPIPV, MMRV
Symptoms: Dry mouth, Headache, Injection site erythema, Injection site swelling, Oropharyngeal pain
Clinical narrative: Headache, sore throat, dry mouth, thirsty, low grade fever, swelling and red at injection site.
Age: 6.0
Sex: F
Vaccine: DTPIPV, MMRV
Symptoms: Pyrexia, Thirst
Clinical narrative: Headache, sore throat, dry mouth, thirsty, low grade fever, swelling and red at injection site.
Age: 56.0
Sex: F
Vaccine: MMR
Symptoms: Joint stiffness, Peripheral swelling
Clinical narrative: Joint stiffness. Extensive swelling of right hand.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site pruritus, Injection site reaction, Injection site swelling, Rash erythematous
Clinical narrative: Red rash, swelling, itching at injection site. Symptoms beginning to resolve, but not completely gone. Advised pt to take Benadryl by mouth and use hydrocortisone cream topically.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pruritus
Clinical narrative: Inflammation, Itching, redness around injection area.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Condition aggravated, Dizziness, Flushing, Hypertension
Clinical narrative: Dizziness, Mild Hypertension (167/94), mild chest tightness, and flushing. Persisted for almost 3 hours, monitored BP levels and administered 12.5mg liquid diphenhydramine for allergic prophylaxis pre-BP monitoring. Had patient rest for duration, released after problem abated.
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Hyperhidrosis, Malaise, Pruritus generalised, Rash
Clinical narrative: Itching Head to toe. Headache. Rash. Patient took Benadryl and reported rash and itching subsided.  Feeling malaise on 08/16/15.  Thinks she may be sweating due to vaccine but works around ovens.
Age: 5.0
Sex: M
Vaccine: IPV, MMR, VARCEL
Symptoms: Blister, Headache, Pyrexia, Rash generalised
Clinical narrative: Fever of 103, headache, rash on back, neck, and front torso. Has not been in contact with any outside individuals, no ability to receive chickenpox due to closed contact. Fever persisted for 2 days, the rash has now spread and multiplied onto entire body surface all areas except internally, with blisters. This was on her 2nd round of immunizations for Varicella, no prior adverse reactions.
Age: 12.0
Sex: M
Vaccine: DTAP, MENHIB
Symptoms: Erythema, Induration, Nausea, Pain, Pyrexia
Clinical narrative: High fever, nauseas, Pain, located swelling, redness, arm was hot and hard.
Age: 12.0
Sex: M
Vaccine: DTAP, MENHIB
Symptoms: Skin warm, Swelling
Clinical narrative: High fever, nauseas, Pain, located swelling, redness, arm was hot and hard.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Blood culture, Blood lactate dehydrogenase, C-reactive protein, Culture urine, Cytomegalovirus test
Clinical narrative: Intermittent fever up to 102 for 10 days following vaccination.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Full blood count, Hepatic enzyme, Mononucleosis heterophile test, Pyrexia, Red blood cell sedimentation rate
Clinical narrative: Intermittent fever up to 102 for 10 days following vaccination.
Age: 50.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Blood pressure increased, Blood test, Cellulitis, Erythema, Fatigue
Clinical narrative: Redness, severe swelling, severe pain. Morphine, KEFLEX, malaise, fatigue, cellulitis. Hydrocodone/APAP-Thurs. Clindamycin-Fri. Warm compress. Hydroxyzine-Fri. Ondansetron-Fri.
Age: 50.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Malaise, Pain, Swelling
Clinical narrative: Redness, severe swelling, severe pain. Morphine, KEFLEX, malaise, fatigue, cellulitis. Hydrocodone/APAP-Thurs. Clindamycin-Fri. Warm compress. Hydroxyzine-Fri. Ondansetron-Fri.
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Fall, Syncope
Clinical narrative: Patient experienced syncope for few second and fell few minutes after receiving Tdap shot.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Pt describes redness/swelling at injection site.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV9, MNQ, TDAP, VARCEL
Symptoms: Pruritus, Urticaria
Clinical narrative: Wheals over face & warms. Itching. Treatment: Prednisone po taper. DEPO-MEDROL. OTC BENADRYL.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site urticaria
Clinical narrative: Large wheal (4-5" across) at injection site. Red, raised and itchy. Patient had gotten some relief by applying witch hazel to site.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 16-MAR-2015 the patient was vaccinated with improperly stored PNEUMOVAX 23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 10-MAR-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2015, dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a nurse referring to a patient of unknown gender, between the age of 30 years and 49 years old, who was enrolled in the patient support program. There was no medical history or concurrent condition reported. On 07-JUL-2015, a vial of (Oka/Merck) VARIVAX underwent temperature excursions, which was at 8.9 degrees Celsius for 1 hour and 28 minutes, and then 0.4 degrees Celsius for 1 hour and 25 minutes on 28-JUL-2015. On 04-AUG-2015 the patient was vaccinated with a dose of the improperly stored vaccine (lot # K026386, expired date 15-DEC-2016, dose and route were unknown). The nurse reported the patient had not experienced any adverse events. It was unknown if there was any relevant laboratory data. As of 05-AUG-2015, it was unknown if the patient continued on (Oka/Merck) VARIVAX. This is one of several reported received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 23-MAR-2015 the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5 (unit unspecified) lot # K0053253 with expiration date of 10-FEB-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 10-FEB-2015 the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5 (unit unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 22-DEC-2014 the patient was vaccinated with improperly stored PNEUMOVAX23 (lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 23-JAn-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 08-JAN-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5(unit unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 09-FEB-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 29-DEC-2014, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 22-JAN-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5 (unit unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 08-JAN-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0 (unit  unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 13-FEB-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a pharmacist concerning a patient of unknown age and gender. There was no pertinent medical history or drug reactions/allergies reported. On 04-AUG-2015 the patient was inadvertently vaccinated with an expired dose of (Oka/Merck) VARIVAX (lot #: J008443 and expiration date: 09-JUL-2015; dose, route and frequency were unspecified). No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 05-JAN-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 26-JAn-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 30-JAN-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 19-JAN-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 13-JAN-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 31-DEC-2014 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 30-DEC-2014  the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 30-MAR-2015 the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5(unit unspecified0, lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and concurrent condition were not reported. On 08-JUL-2015, the nurse reported that the patient received a dose of improperly stored (Oka/Merck) VARIVAX (dose, frequency and route were unknown, lot # K009757, expiration date 09-JUL-2016; lot # L008272, expiration date 11-MAR-2017). No concomitant medication was reported. No adverse effects were reported. There were no product quality complaints PQC involved. Additional information has been requested.
Age: 60.0
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a pharmacist refers to a 60 year old patient of unknown gender. Information concerning medical history and concurrent condition was not reported. The patient had no drug allergies and reactions. On 14-JUL-2015 the patient was vaccinated with ZOSTAVAX (dose, strength and route were not reported, lot # L011533, expiration date: 03-JUL-2016). There was no concomitant therapy reported. On 16-JUL-2015 the patient contacted the pharmacy complaining of injection site redness and injection site swelling which were started on an unknown date in July 2015. The patient referred to an unspecified physician for medical attention and was treated with KEFLEX. No lab diagnostics studies were performed. The events had went down (also reported as OK) at the time of report. The reporter was requesting a lot check. This case is one of several cases received from the same source. Additional information has been requested.
Age: 64.0
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a pharmacist referring to a 64 year old patient of unknown gender. Information concerning medical history and concurrent condition was not reported. The patient had taken Sulfa and had unspecified pain medication. On 03-AUG-2015 the patient was vaccinated with ZOSTAVAX (0.65 ml, once, lot # L011533, expiration date: 03-JUL-2016, subcutaneous). There was no concomitant therapy reported. On 04-AUG-2015 (also reported as "a day later"), the patient experienced injection site red and injection site swelling. There was no treatment given for the events. No lab diagnostics studies were performed. The patient had sought medical attention via calling the pharmacy. The reporter was requesting a lot check. This case is one of several cases received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 24-FEB-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to a patient of unknown age and gender Information about medical history and concurrent condition was not reported. On 13-FEB-2015 the patient was vaccinated with improperly stored PNEUMOVAX23 lot # K010465 with expiration date of 23-MAR-2016; dosage and route unspecified (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Asthenia, Blood test, Computerised tomogram, Dysphagia, Feeling abnormal
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Mobility decreased, Nuclear magnetic resonance imaging
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Weight decreased
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Dizziness, Eating disorder, Gait disturbance, Guillain-Barre syndrome, Speech disorder
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Asthenia, Back pain, Computerised tomogram normal, Constipation, Dizziness
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Dizziness postural, Dysgeusia, Dyspnoea, Eating disorder, Electrocardiogram normal
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Eyelid function disorder, Fall, Flank pain, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Immunoglobulin therapy, Injection site pain, Lacrimation increased, Loss of consciousness, Lumbar puncture abnormal
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Mobility decreased, Neck pain, Nuclear magnetic resonance imaging normal, Renal pain, Respiratory tract congestion
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 72.0
Sex: M
Vaccine: PNC13, PNC13, PNC13
Symptoms: Visual impairment, Walking aid user, Weight decreased
Clinical narrative: Dizzy, speech, eating, eyes, walking. Medical center 6/4 to 6/15. Rehab hospital 6/15 to 7/8/15. Guillain Barre Syndrome.
Age: 74.0
Sex: F
Vaccine: PNC13, PNC13, PNC13
Symptoms: C-reactive protein increased, Groin pain, Injection site reaction, Musculoskeletal pain, Musculoskeletal stiffness
Clinical narrative: Arms, legs very painful, went back to Dr office and was told I had polymyalgia rheumatica, was not sick prior to this vaccine, now I am taking prednisone for how long? Still sick.
Age: 74.0
Sex: F
Vaccine: PNC13, PNC13, PNC13
Symptoms: Polymyalgia rheumatica, Red blood cell sedimentation rate increased, Vaccination site pain
Clinical narrative: Arms, legs very painful, went back to Dr office and was told I had polymyalgia rheumatica, was not sick prior to this vaccine, now I am taking prednisone for how long? Still sick.
Age: 74.0
Sex: F
Vaccine: PNC13, PNC13, PNC13
Symptoms: Abasia, C-reactive protein increased, Insomnia, Mobility decreased, Musculoskeletal pain
Clinical narrative: Arms, legs very painful, went back to Dr office and was told I had polymyalgia rheumatica, was not sick prior to this vaccine, now I am taking prednisone for how long? Still sick.
Age: 74.0
Sex: F
Vaccine: PNC13, PNC13, PNC13
Symptoms: Pain in extremity, Red blood cell sedimentation rate increased
Clinical narrative: Arms, legs very painful, went back to Dr office and was told I had polymyalgia rheumatica, was not sick prior to this vaccine, now I am taking prednisone for how long? Still sick.
Age: 74.0
Sex: F
Vaccine: PNC13, PNC13, PNC13
Symptoms: Blood test, Malaise, Myalgia, Pain in extremity
Clinical narrative: Arms, legs very painful, went back to Dr office and was told I had polymyalgia rheumatica, was not sick prior to this vaccine, now I am taking prednisone for how long? Still sick.
Age: 15.0
Sex: M
Vaccine: HPV9
Symptoms: Blood test normal, Confusional state, Pyrexia, Vomiting
Clinical narrative: Dr misinformed us that the HPV vaccine is required for school. High fever between 102 to 105 F over two days. Vomit few times.  We took him to ER on 16th. Confusion occurred in the morning of 17th, and we called an ambulance.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Eye movement disorder, Hypotonia, Loss of consciousness
Clinical narrative: The child was given immunizations by the nurse and shortly after receiving them she went limp in her grandmothers arms, her eyes rolled back and she appeared to lose consciousness.  The child quickly regained consciousness, her blood pressure and pulse were stable and she was afebrile.  Her mother reported that she had not eaten or drank since breakfast that morning.  Mother also reported that the child did not know she was going to receive vaccines that day until the nurse came into the room with them.  Mother also states that the child sometimes holds her breath when upset or angry.
Age: 43.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site swelling
Clinical narrative: Severe itching at site of vaccine, swelling and redness.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling redness at injection site. Pt used ice and Benadryl to reduce reaction.
Age: 0.21
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Incorrect product formulation administered
Clinical narrative: Pentacel given without HIB portion.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Influenza like illness, Peripheral swelling, Rash
Clinical narrative: Employee received injection on 8/14/15, she reported that on 8/15/15 she woke up with a non-itchy rash down her arm and leg and arm was swollen, went away in the evening. On 8/16/15, she woke with flulike symptoms, no fever, no more rash. 8/17/15 back to normal.